Clinical Trial Update: Study to Investigate LP352 in Subjects With Developmental and Epileptic Encephalopathies [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update indicates LP352 has completed Phase 1/2 studies in developmental and epileptic encephalopathies. The program covers Dravet Syndrome and Le…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Developmental and Epileptic Encephalopathy
• Dravet Syndrome
• Lennox-gastaut Syndrome

Drugs mentioned

• LP352

Snippet

Sponsor: Longboard Pharmaceuticals | Conditions: Developmental and Epileptic Encephalopathy, Dravet Syndrome | Phase 1, Phase 2 | Status: COMPLETED